Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 608Pancreatic Neoplasms 371Carcinoma, Hepatocellular 284Stomach Neoplasms 236Rectal Neoplasms 173Colonic Neoplasms 162Carcinoma, Non-Small-Cell Lung 160Esophageal Neoplasms 158Breast Neoplasms 138Neoplasms 126Neoplasm Metastasis 123Ovarian Neoplasms 114Lung Neoplasms 104Cholangiocarcinoma 101Liver Neoplasms 95Gastrointestinal Neoplasms 93Melanoma 82Biliary Tract Neoplasms 74Prostatic Neoplasms 71Esophageal Squamous Cell Carcinoma 66Endometrial Neoplasms 66Sarcoma 54Squamous Cell Carcinoma of Head and Neck 53Carcinoma, Renal Cell 53Uterine Cervical Neoplasms 47Adenocarcinoma Of Esophagus 45Head and Neck Neoplasms 44Urinary Bladder Neoplasms 39Triple Negative Breast Neoplasms 37Gastrointestinal Stromal Tumors 34

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Gastrointestinal × 90 days × Clear all
NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

Terminated
1,865 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡